Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies reported strong financial guidance for Q4 2022, anticipating revenue exceeding $250 million, surpassing previous estimates of $232-$240 million. For the full year 2022, revenue is expected to exceed $900 million, with earnings per diluted share anticipated to be over $1.45 in Q4 and exceed $5.00 for the full year. CEO Mary Puma emphasized robust customer demand for the Purion product family, hinting at year-over-year growth in 2023, supported by favorable foreign exchange impacts on earnings.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 25th Annual Needham Growth Conference, scheduled for January 10-11, 2023, at the Lotte New York Palace Hotel and virtually on January 12, 2023. The company will present on January 11th at 2:15 p.m. EST, with management available for one-on-one meetings. A live webcast will be accessible from Axcelis' website, with a replay available for 30 days after the event. Axcelis has been a key player in the semiconductor industry for over 40 years, focusing on ion implantation systems.
Axcelis Technologies (Nasdaq: ACLS) announced multiple shipments of the Purion Dragon™ high current implanter, including a follow-on order and a new customer evaluation aimed at semiconductor manufacturers in Asia. These shipments are part of Q4 2022 activities and support advanced memory and logic device development. Executive VP Greg Redinbo emphasized the Purion Dragon's capabilities, highlighting its advanced process control and productivity gains for high current applications. This move reinforces Axcelis' commitment to innovation in the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) will showcase its innovative Purion and GSD Ovation Series ion implanters at SEMICON Japan 2022, held from December 14-16 in Tokyo. The event aims to highlight technologies that support power device, image sensor, memory, and logic markets. Key products include the Purion Power Series for silicon processing and the Purion XE Series with Boost Technology for advanced image sensors. Axcelis aims to expand its market share in Japan by meeting the increasing demand from chipmakers with these advanced solutions.
Axcelis Technologies (NASDAQ: ACLS) will participate in the 11th Annual NYC Summit on December 13, 2022, in New York City. The event features small group meetings between investors and company management teams. Presentation materials will be accessible on Axcelis' investor page. The NYC Summit is invitation-only for accredited investors and research analysts, with RSVP required by December 1, 2022. Axcelis has a strong track record in providing ion implantation solutions for the semiconductor industry, serving the market for over 40 years.
Summary not available.
On Nov. 17, 2022, Axcelis Technologies (Nasdaq: ACLS) announced its founding membership in the Semiconductor Climate Consortium (SCC), aimed at combating climate change within the semiconductor industry. President and CEO Mary Puma emphasized this membership enhances Axcelis' sustainability efforts through collaboration. The SCC focuses on pooling industry resources to tackle decarbonization challenges and sets collective sustainability goals. Axcelis has over 40 years of experience in providing innovative ion implantation solutions critical to integrated circuit manufacturing.
On November 10, 2022, Axcelis Technologies (Nasdaq: ACLS) announced significant new shipments of its Purion Power Series ion implanter systems to various fabs in Asia and Europe. This includes the first SiC tool shipped from their South Korea operations. Key models shipped are the Purion H200, Purion XE, and Purion M, aimed at high-volume production of Si and SiC power devices. CEO Mary Puma highlighted continued growth in the power device market and emphasized the company's technological advantages and market share prospects.
Axcelis Technologies reported a strong financial performance in Q3 2022, with revenue of $229.2 million, up from $221.2 million in Q2. Operating profit decreased slightly to $53.2 million, while net income was $40.3 million, or $1.21 per diluted share, down from $44.2 million or $1.32 per diluted share. Gross margin improved to 45.1%. The company also reported a record systems backlog of $1.1 billion and booking of $337.1 million. For Q4 2022, Axcelis expects revenue of $232-240 million and operating profit of $41-45 million.
Axcelis Technologies (Nasdaq: ACLS) announced shipments of its PurionH™ and PurionXE™ implanters to a major analog chip manufacturer in North America. This follows a series of multi-year purchase orders aimed at enhancing the chipmaker's manufacturing capabilities. CEO Mary Puma highlighted the customer's confidence in Axcelis, reflecting strong business relationships.
The company has over 40 years of experience in the semiconductor sector, focusing on high-productivity solutions and support for critical ion implantation processes.